PPT-Glycemic Management of Type 2 Diabetes

Author : faustina-dinatale | Published Date : 2018-10-06

1 AACE Comprehensive Care Plan Handelsman YH et al Endocr Pract 201521suppl 1187 2 Therapeutic Lifestyle Change Glycemic Management of Type 2 Diabetes 3 Components

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Glycemic Management of Type 2 Diabetes" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Glycemic Management of Type 2 Diabetes: Transcript


1 AACE Comprehensive Care Plan Handelsman YH et al Endocr Pract 201521suppl 1187 2 Therapeutic Lifestyle Change Glycemic Management of Type 2 Diabetes 3 Components of Therapeutic Lifestyle Change. 1. AACE Comprehensive Care Plan. 2. Handelsman Y, et al. . Endocr Pract. . 2011;17(suppl 2):1-53.. Glycemic Management in Type 2 Diabetes. Therapeutic Lifestyle Change. 3. Components of Therapeutic Lifestyle Change. Monitoring for Glycemic Control. Chapter 9. Lori Berard, Ian Blumer, Robyn Houlden, David Miller, Vincent Woo. Key Messages. Glycated hemoglobin (. A1C. ) .  . measure every 3 months . (6 months if stable at target). 1. J. V Akinlotan, . 2. I.O Olayiwola, . 3. A Ladokun and . 4. S.A Sanni . 1. Nutrition and Dietetics Department, Moshood Abiola Polytechnic Abeokuta. 2,4. Nutrition and Dietetics Department, Federal University of Agriculture Abeokuta. 1c. Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes. Goals. HbA. 1c. Targets: HEDIS and ADA. Objectives for Treatment of T2D. ADA/EASD Recommendations for HbA. 1c. Approach for Individualizing Glycemic Targets. Glycemic. Variability for Diabetes Management. Matthew Wiley, . Razvan. . Bunescu. , Cindy Marling,. Jay . Shubrook. and Frank Schwartz. School of Electrical Engineering and Computer Science. Appalachian Rural Health Institute Diabetes and Endocrine Center. Efficacy and Safety of Modern Antihyperglycemic Therapies. 1. DPP-4 Inhibitors. 2. DPP-4 Inhibitors. FDA-Approved . Agents. Alogliptin. Linagliptin. Saxagliptin. Sitagliptin. Key . Features. Oral administration. Glimepiride, Metformin & . Voglibose. Combination in T2DM. Dr. Mohammed Riyaz . M.D (Medicine), Masters . in . Endocrinology(UK). Chief . Endocrinologist. & Medical Director (EDSC). Type 2 diabetes population requiring stringent . Permission is required from the Association for any commercial use or for reproduction in any print materials. (contact . permissions@diabetes.org) . Standards of Medical Care in Diabetes - 2018. Standards of Care. A Network Meta-Analysis. Vanessa Ha, PhD Student. Supervisors: Drs. Sonia . Anand. and Russell de Souza. Complications of Gestational Diabetes Mellitus. High blood pressure. &. pre-eclampsia. Type 2 diabetes. STANDARDS OF MEDICAL CARE IN DIABETES - 2019 Guidelines Update Ann Marie Blair, DNP, FNP, NP - C, BC - ADM, CDE Piedmont Columbus Regional Presenter Financial Relationships Disclosure Ann M. Blair, INTRODUCTION The concept of the glycemic index (GI) wasintroduced as a means of classifying carbohydrate containingfoods based on the blood glucose response after food consump-tion. The GI is define : Long-term hyperglycemia promotes development of complications and suboptimal well-being in patients with diabetes. A stringent glycemic control is a worldwide standard of diabetes care recommended i for HCSWs. Katharine Ramage. Diabetes MCN Professional Education Lead/DSN. Learning Outcomes. Develop an understanding of the different types of diabetes, risk factors for developing diabetes, how it can present and how it is diagnosed. Agent-Specific Considerations. Joshua J. Neumiller, PharmD, CDE, FAADE, FASCP. Vice-Chair & Associate Professor. College of Pharmacy and Pharmaceutical Sciences . Washington State University. Presenter Disclosure Information.

Download Document

Here is the link to download the presentation.
"Glycemic Management of Type 2 Diabetes"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents